Home Dialysis Systems Market Updates

Global Home Dialysis Systems Market size was valued at USD 22.34 billion in 2023 and is poised to grow from USD 24.69 billion in 2024 to USD 54.87 billion by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032). 

The global home dialysis systems market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Fresenius Medical Care AG & Co. KGaA (Germany) ', 'Baxter International Inc. (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Medtronic plc (Ireland) ', 'Nipro Corporation (Japan) ', 'Asahi Kasei Medical Co., Ltd. (Japan) ', 'Diaverum (Sweden) ', 'Kimal plc (United Kingdom) ', 'Becton, Dickinson and Company (BD) (United States) ', 'Quanta Dialysis Technologies (United Kingdom) ', 'Outset Medical, Inc. (United States) ', 'Rockwell Medical, Inc. (United States) ', 'Dialife SA (Switzerland) ', 'Medivators Inc. (United States) ', 'Nikkiso Co., Ltd. (Japan) ', 'NantHealth, Inc. (United States) '

The market is expanding due to technical advancements, transplant risks, growth in the frequency of chronic renal disorders, efforts by large players to develop improved products and services, and a lack of organ donors. Outset Medical, Inc., a medical technology business whose aim is to minimize the complexity and cost of dialysis, has joined Health Home, an alliance of innovative healthcare companies whose mission is to radically change policymakers' perceptions of home diagnostics. They hope to persuade authorities to reconsider the home as a clinical treatment facility for chronic disease management through collaboration in the healthcare sector. These initiatives are projected to drive market growth during the forecast period.

The use of peritoneal dialysis, whose products are portable and offer convenience, particularly at patients' homes, is a key trend in the global market for home dialysis systems. It is popular among the elderly because it does not require the patient to be awake. As a result, several market players are developing peritoneal dialysis products, and some are also conducting research and development (R&D) to advance the technology.

North America dominated the home dialysis systems market in 2021, with a revenue share of more than 38.40%. Significant government investments in the creation of novel medical devices, the existence of important participants, and the presence of a good reimbursement system are all contributing to the region's market growth. Home dialysis is becoming more popular as the prevalence of chronic kidney disease (CKD) rises. Other factors influencing market growth include rising healthcare spending, increasing disposable income, and government efforts. For example, Innovate Kidney Care, a new initiative supported by nine leading healthcare organizations, will launch in June 2021 to increase patient options for receiving home dialysis support and training. Among the initial members are CVS Kidney Care, Anthem, Inc., the American Society of Nephrology (ASN), Cricket Health, Intermountain Healthcare, Outset Medical, Inc., the National Kidney Foundation (NKF), and Strive Health. Innovate Kidney Care's purpose is to achieve four goals: better patient outcomes, better healthcare practitioner experience, better patient experience, and lower healthcare expenditures.